Alex Thurman
Director of Finance/CFO at GLAUKOS CORPORATION
Net worth: 5 M $ as of 29/04/2024
Alex Thurman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GLAUKOS CORPORATION | Director of Finance/CFO | 31/03/2022 | - |
| Chief Administrative Officer | 30/06/2016 | 30/11/2016 | |
| Comptroller/Controller/Auditor | 30/06/2016 | 30/11/2016 | |
| Corporate Officer/Principal | 30/11/2016 | 31/03/2022 | |
| ALLERGAN PLC | Director of Finance/CFO | 30/11/2016 | - |
Career history of Alex Thurman
Training of Alex Thurman
| Brigham Young University | Graduate Degree |
Statistics
International
| United States | 3 |
| Ireland | 2 |
Operational
| Director of Finance/CFO | 2 |
| Chief Administrative Officer | 1 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Alex Thurman
- Experience
